Frederick J. Lynch - 21 Mar 2022 Form 4 Insider Report for H-CYTE, INC. (HCYT)

Role
10%+ Owner
Signature
/s/ Frederick J. Lynch
Issuer symbol
HCYT
Transactions as of
21 Mar 2022
Transactions value $
$233,010
Form type
4
Filing time
23 Mar 2022, 08:00:59 UTC
Previous filing
17 Feb 2022
Next filing
02 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCYT COMMON STOCK Exercise of in-the-money or at-the-money derivative security $116,505 +8,321,785 $0.0140 8,321,785 21 Mar 2022 (SEE FOOTNOTE) F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCYT STOCK PURCHASE WARRANTS Exercise of in-the-money or at-the-money derivative security -8,321,785 -31.8% 17,886,434 21 Mar 2022 COMMON STOCK 8,321,785 $0.0140 (SEE FOOTNOTE) F1, F2
transaction HCYT STOCK PURCHASE WARRANTS Other $116,505 +8,321,785 $0.0140 8,321,785 21 Mar 2022 COMMON STOCK 8,321,785 $0.0140 (SEE FOOTNOTE) F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
F2 Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing.
F3 Represents five-year inducement warrants received from the issuer in connection with the exercise of the ten-year warrants.